Synektik (FRA:A2P) Cyclically Adjusted FCF per Share: €0.66 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:A2P Synektik SA FRA:A2P
67 GF Score
Price €87.35
GF Value €53.38
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Synektik Cyclically Adjusted FCF per Share?

Synektik FRA:A2P +0.34% 67 Cyclically Adjusted FCF per Share is €0.66 as of Mar. 2026. GuruFocus rates FRA:A2P with a GF Score™ of 67/100 and a GF Value™ of €53.38 (Significantly Overvalued). The stock has 7 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Synektik's adjusted free cash flow per share for the three months ended in Mar. 2026 was €-0.879. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €0.66 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Synektik's average Cyclically Adjusted FCF Growth Rate was 73.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2026-07-21), Synektik's current stock price is €87.35. Synektik's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was €0.66. Synektik's Cyclically Adjusted Price-to-FCF of today is 132.35.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Synektik was 148.02. The lowest was 39.00. And the median was 100.91.


Synektik  (FRA:A2P) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Synektik's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=87.35/0.66
=132.35

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Synektik was 148.02. The lowest was 39.00. And the median was 100.91.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Synektik Cyclically Adjusted FCF per Share Related Terms


Synektik Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Synektik's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Synektik Cyclically Adjusted FCF per Share Chart

Synektik Annual Data
Trend Dec15 Dec16 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.34 0.55

Synektik Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.38 0.51 0.55 0.78 0.66

FRA:A2P vs ABT, SYK, MDT: Cyclically Adjusted FCF per Share Comparison

For the Medical Devices subindustry, Synektik's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Synektik Cyclically Adjusted Price-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Synektik's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Synektik's Cyclically Adjusted Price-to-FCF falls into.


FRA:A2P
67GF Score
Synektik SA FRA:A2P
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Synektik Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Synektik's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.879/163.0700*163.0700
=-0.879

Current CPI (Mar. 2026) = 163.0700.

Synektik Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201603 -0.414 98.983 -0.682
201606 0.000 99.552 0.000
201609 -0.119 99.064 -0.196
201612 0.130 100.366 0.211
201703 -0.209 101.018 -0.337
201706 -0.046 101.180 -0.074
201709 -0.092 101.343 -0.148
201803 -0.499 102.564 -0.793
201806 -0.023 103.378 -0.036
201809 0.194 103.378 0.306
201812 0.715 103.785 1.123
201903 -0.351 104.274 -0.549
201906 -0.230 105.983 -0.354
201909 0.081 105.983 0.125
201912 0.266 107.123 0.405
202003 -0.421 109.076 -0.629
202006 0.260 109.402 0.388
202009 0.130 109.320 0.194
202012 0.316 109.565 0.470
202103 -0.034 112.658 -0.049
202106 0.031 113.960 0.044
202109 0.177 115.588 0.250
202112 0.403 119.088 0.552
202203 -0.946 125.031 -1.234
202206 0.157 131.705 0.194
202209 -0.053 135.531 -0.064
202212 1.054 139.113 1.236
202303 0.036 145.950 0.040
202306 -0.148 147.009 -0.164
202309 1.375 146.113 1.535
202312 3.041 147.741 3.357
202403 -2.028 149.044 -2.219
202406 0.095 150.997 0.103
202409 0.091 153.439 0.097
202412 2.815 154.660 2.968
202503 -1.871 157.021 -1.943
202506 -0.162 157.509 -0.168
202509 0.817 158.000 0.843
202512 2.548 158.320 2.624
202603 -0.879 163.070 -0.879

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of €0.66 mean?
Synektik (FRA:A2P) has a Cyclically Adjusted FCF per Share of €0.66 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Synektik and its competitors.
Is Synektik's Cyclically Adjusted FCF per Share too high?
Synektik's current Cyclically Adjusted FCF per Share is €0.66. Overall, Synektik has a GF Score™ of 67/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Synektik's Cyclically Adjusted FCF per Share compare to ABT and SYK?
Synektik's Cyclically Adjusted FCF per Share of €0.66 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted FCF per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Synektik and its competitors. Synektik's current Cyclically Adjusted FCF per Share is €0.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Synektik stock overvalued right now?
Based on GuruFocus' analysis, Synektik (FRA:A2P) is currently considered Significantly Overvalued. The stock's GF Value™ is €53.38, compared to a current price of €87.35 — trading 63.6% above its estimated fair value. The current Cyclically Adjusted FCF per Share is €0.66. Synektik's overall GF Score™ is 67/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Synektik (FRA:A2P), the current Cyclically Adjusted FCF per Share is €0.66 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Synektik (FRA:A2P) Overvalued in 2026?

Based on GuruFocus' analysis, Synektik stock appears to be overvalued. The current stock price of €87.35 is trading 63.6% above its estimated GF Value™ of €53.38. GuruFocus considers Synektik to be Significantly Overvalued.

Key valuation signals for FRA:A2P:

  • Cyclically Adjusted FCF per Share: €0.66
  • GF Value™: €53.38 vs. price of €87.35 (63.6% above fair value)
  • GF Score™: 67/100 with 7 warning signs

No single metric tells the full story. See the FRA:A2P stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Synektik Business Description

Other Exchanges SNT:Poland
Address Aleja Wincentego Witosa 31, Warsaw, POL, 00-710
Synektik SA is a supplier of innovative products, services and IT solutions for diagnostic imaging and nuclear medicine. It sells medical devices and IT solutions used in radiology and operates research laboratory for diagnostic imaging systems and a service centre for medical equipment. Its operating segments include the sale of medical equipment used in radiology and nuclear medicine and IT solutions, Maintenance services for medical equipment as well as acceptance and specialist tests and Radiopharmaceutical production.
67GF Score

Get the complete analysis for FRA:A2P

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€87.35
Price
€53.38
GF Value